Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1dub | CAA | Enoyl-CoA hydratase, mitochondrial | 4.2.1.17 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 1dub | CAA | Enoyl-CoA hydratase, mitochondrial | 4.2.1.17 | 1.000 | |
| 1mj3 | HXC | Enoyl-CoA hydratase, mitochondrial | 4.2.1.17 | 0.635 | |
| 3q0g | COA | Probable enoyl-CoA hydratase echA8 | 4.2.1.17 | 0.620 | |
| 1ey3 | DAK | Enoyl-CoA hydratase, mitochondrial | 4.2.1.17 | 0.618 | |
| 2dub | CO8 | Enoyl-CoA hydratase, mitochondrial | 4.2.1.17 | 0.571 | |
| 3q0g | BCO | Probable enoyl-CoA hydratase echA8 | 4.2.1.17 | 0.566 | |
| 1nzy | BCA | 4-chlorobenzoyl coenzyme A dehalogenase | 3.8.1.7 | 0.550 | |
| 1jxz | BCA | 4-chlorobenzoyl coenzyme A dehalogenase | 3.8.1.7 | 0.546 | |
| 5aaj | HSC | Peroxisomal bifunctional enzyme | 1.1.1.35 | 0.543 | |
| 4qij | 1HA | 1,4-dihydroxy-2-naphthoyl-CoA synthase | / | 0.489 | |
| 3cx5 | SMA | Cytochrome b | / | 0.485 | |
| 5bt4 | 2LO | Bromodomain-containing protein 4 | / | 0.474 | |
| 2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.473 | |
| 1kyo | SMA | Cytochrome b | / | 0.472 | |
| 3cxh | SMA | Cytochrome b | / | 0.471 | |
| 2qjy | SMA | Cytochrome b | / | 0.470 | |
| 4i42 | 1HA | 1,4-dihydroxy-2-naphthoyl-CoA synthase | / | 0.465 | |
| 1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.464 | |
| 2wle | COA | Polysialic acid O-acetyltransferase | / | 0.464 | |
| 3a0i | AJI | Glucokinase | 2.7.1.2 | 0.463 | |
| 4xwr | FAD | Cholesterol oxidase | 1.1.3.6 | 0.459 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.458 | |
| 2yiu | SMA | Cytochrome b | / | 0.458 | |
| 3t88 | S0N | 1,4-dihydroxy-2-naphthoyl-CoA synthase | / | 0.457 | |
| 3pwh | ZMA | Adenosine receptor A2a | / | 0.457 | |
| 1ezv | SMA | Cytochrome b | / | 0.456 | |
| 2ibz | SMA | Cytochrome b | / | 0.456 | |
| 4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
| 4xxg | FAD | Cholesterol oxidase | 1.1.3.6 | 0.456 | |
| 1p7t | ACO | Malate synthase G | / | 0.455 | |
| 3gwn | FAD | Probable FAD-linked sulfhydryl oxidase R596 | 1.8.3.2 | 0.455 | |
| 4mle | VO1 | Glucokinase | 2.7.1.2 | 0.455 | |
| 1xuo | LA1 | Integrin alpha-L | / | 0.454 | |
| 4gb9 | 0WR | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
| 1n4u | FAE | Cholesterol oxidase | 1.1.3.6 | 0.453 | |
| 1q5d | EPB | Epothilone C/D epoxidase | 1.14 | 0.452 | |
| 1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.452 | |
| 4xuh | SFI | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
| 3ssn | MVI | Mycinamicin VI 2''-O-methyltransferase | / | 0.451 | |
| 4ia3 | BIV | Vitamin D3 receptor A | / | 0.451 | |
| 4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.449 | |
| 1mxt | FAE | Cholesterol oxidase | 1.1.3.6 | 0.447 | |
| 3oia | A31 | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
| 1nde | MON | Estrogen receptor beta | / | 0.446 | |
| 2hcd | BIV | Vitamin D3 receptor A | / | 0.446 | |
| 2wet | FAD | Tryptophan 5-halogenase | / | 0.446 | |
| 3vso | EK1 | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
| 4bge | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
| 3rfm | CFF | Adenosine receptor A2a | / | 0.446 | |
| 1q51 | CAA | 1,4-dihydroxy-2-naphthoyl-CoA synthase | / | 0.445 | |
| 3aba | FLI | Cytochrome P450 | / | 0.445 | |
| 4ejn | 0R4 | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.445 | |
| 2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.444 | |
| 2ze2 | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.444 | |
| 3l9m | L9M | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
| 4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.443 | |
| 1olm | VTQ | SEC14-like protein 2 | / | 0.442 | |
| 1ybg | TAV | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | / | 0.442 | |
| 2dvl | FAD | Acyl-CoA dehydrogenase | / | 0.442 | |
| 3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.442 | |
| 4iah | 1DX | Alr2278 protein | / | 0.442 | |
| 2pr2 | DG1 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
| 2qjp | SMA | Cytochrome b | / | 0.441 | |
| 3iw1 | ASD | Steroid C26-monooxygenase | 1.14.13.141 | 0.441 | |
| 4bgi | I4I | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.441 | |
| 1cc2 | FAD | Cholesterol oxidase | 1.1.3.6 | 0.440 | |
| 3rhh | NAP | NADP-dependent glyceraldehyde-3-phosphate dehydrogenase | / | 0.440 | |
| 4ia2 | BIV | Vitamin D3 receptor A | / | 0.440 | |
| 4u2l | SFD | Cholesterol oxidase | 1.1.3.6 | 0.440 |